Evotec announced on March 10 plans to lay off around 800 employees, impacting about one-sixth of its ~4,800-5,000 workforce, as part of the 'Horizon' phase of its reorganization123
The company will close four additional sites over the next two years, reducing total sites from 14 to 10; known closures include Framingham (US), Abingdon (UK), Munich (Germany), and Lyon (France)135
This follows prior cuts of 600 jobs and site reductions from 19 to 14 between 2024-2025123
Measures aim to save 75 million euros by end of 2027, with 100 million euros in restructuring costs from 2026-2028; implementation starts H2 2026, mostly complete by 202712
CEO Christian Wojczewski stated Horizon transforms the operating model for stronger performance through 2027 and growth toward 2030, targeting >1 billion euros revenue123
Sources:
1. https://www.fiercebiotech.com/biotech/evotec-reveals-sweeping-800-person-layoffs-more-site-closures-restructuring-rolls
2. https://www.marketscreener.com/news/evotec-accelerates-restructuring-job-cuts-and-site-closures-trigger-stock-plunge-ce7e5fdede8df123
3. https://pharmaphorum.com/news/evotec-slashes-staff-turnaround-plan-gathers-pace
5. https://www.bizjournals.com/boston/news/2026/03/11/evotec-closing-framingham-site.html